In July 2021 API Consumer Brands announced its exit from the New Zealand pharmaceutical market, thus affecting the supply of a number of important products.
Max Health has since taken over the supply for the following API products.
Name: Buccastem (Prochlorperazine Maleate) tablets
Strength: 3mg x 50
Onelink Code: PHE274
Pharmacode: 340537
Price: POA
Buccastem tablets are listed in Section B of the Pharmaceutical Schedule.
Name: Syntometrine (Oxytocin and Ergometrine) Injection
Strength: 5IU/mL oxytocin 0.5mg/mL ergometrine in 5 x 1mL ampoules
Onelink Code: 256269
Pharmacode: CSP012
Price: POA
Syntometrine injection is currently listed in both Section B and H of the Pharmaceutical Schedule and will enjoy sole supply in the latter from December 1, 2022.
These products will be supplied by our UK partner, Alliance. This partnership continues to exemplify the reliability and integrity of Alliance; Max Health looks forward to growing their portfolio in New Zealand.
The aforementioned products from Alliance are available now from OneLink, as is the rest of the extensive portfolio Max Health offers. These can be ordered from:
Phone: 0800 70 80 60
Fax: 0800 26 69 60
E-mail: customerservices@onelink.co.nz
